AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of CPAP on 6-Minute Walk Test Outcomes in Patients With ECAC

RecruitingNAAges 18 Years - anyAllBeth Israel Deaconess Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The purpose of this protocol is to perform a prospective, randomized, double-blinded, pacebo-controlled clinical trial to determine the influence of a non-invasive positive pressure ventilation device on exercise capacity and symptoms in adult patients with ECAC. Primary outcome will include the total distance traversed by the study subject during a standard 6-minute walk test, and secondary outcomes will include peak flow measurement and symptom reporting before and after the exercise testing. The study will focus on the use of continuous positive airway pressure (CPAP) device. CPAP is FDA-approved for the treatment of various medical conditions, including obstructive sleep apnea and heart failure, but is not FDA-approved for the treatment of ECAC. The study will enroll 32 ambulatory study subjects with confirmed ECAC at the BIDMC, and each study subject will be monitored for up to 3 mo

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient with a diagnosis of ECAC either via bronchoscopy or CT Scan * Age \> 18 years * Patients that will undergo a diagnostic or therapeutic bronchoscopy as part of their standard of care * Patients with a baseline 6 MWT * Patients that have never used CPAP devices in the past Exclusion Criteria: * Patients with poorly-controlled respiratory comorbidities (asthma, COPD, obstructed sleep apnea, GERD, relapsing polychondritis) * No evidence for acute respiratory tract infection, or respiratory tract infection within the prior 3 weeks * Resting bradycardia (\<50 beats/min), frequent multifocal PVCs, complex ventricular arrhythmia, sustained SVT * Dysrhythmia that might pose a risk during exercise or training * Any disease or condition that interferes with completion of initial or follow-up assessments * Subject has co-morbidities that may significantly reduce subject's ability to improve exercise capacity (e.g., severe arthritis, planned knee surgery) or baseline limitation on 6MWT is not due to dyspnea. * Subject has an inability to walk \>140m (150 yd) in 6 minutes * Subject has an inability to tolerate bronchoscopy under moderate sedation or general anesthesia. * Subject has a known sensitivity to drugs required to perform bronchoscopy.
๐Ÿ’Š

What it tests

  • Continuous positive airway pressure (CPAP) device
  • Sham-continuous positive airway pressure (CPAP) device
๐Ÿ“

Where

1 site
Beth Israel Deaconess Medical Center
Boston, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy